---
$id: https://graph.org.ai/products/commodity/51111646
$type: Product
source: UNSPSC
code: "51111646"
title: "Nelarabine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nelarabine

**UNSPSC Code**: 51111646
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a purine antagonist with the molecular formula C11H15N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 60158CV180, chemically known as 9h-purin-2-amine, 9beta-d-arabinofuranosyl-6-methyl- but generally known as nelarabine, which bears US NIH Compound Identifier 151121. European Medicines Agency schedules Nelarabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09188MIG. World Health Organization schedules nelarabine in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, NELARABINE remains the US FDA Preferred Term for this commodity. Nelarabine bears US NLM identifiers UMLS ID C0907349 and NCI Concept Code C1704. SMILES: COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N. .

